Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Transitional change of the relationship between clinical efficacy of treatment for pulmonary MAC disease and drug-sensitivity test for MAC isolated. Eur Respir J 2011; 38: Suppl. 55, 3398

Member's Comments

No comment yet.

Related content which might interest you: Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Clinical manifestation and pulmonary function test after post tuberculosis treatment Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 The relationship between clinical prediction markers, radiological characteristics and 6 month outcome following acute pulmonary embolism Source: Annual Congress 2010 - Clinical management of venous thrombosis, pulmonary embolism and thrombophilia Year: 2010 Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary tuberculosis; a clinical trial Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008 Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Comparing outcomes internationally in pulmonary sarcoidosis: PFT change by scadding stage Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens Source: Annual Congress 2011 - Tuberculosis in special populations Year: 2011 Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002 Effects and feasibility of different types of endurance training in patients with end stage lung disease before lung transplantation Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition) Year: 2011 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia Source: Annual Congress 2011 - Early diagnosis in primary care Year: 2011 Which treatment for which patient with an acute exacerbation of pulmonary hypertension? Source: Annual Congress 2010 - The acute right heart syndrome in the intensive care unit: a hidden world? Year: 2010 The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 6s Year: 2006 Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007 Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment. Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 Efficacy and safety of antibiotic treatment of stable COPD Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations Year: 2010 Efficacy of different preoperational treatment in patients with destructive pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005